Printer Friendly

SCIMED ANNOUNCES THIRD QUARTER RESULTS

 SCIMED ANNOUNCES THIRD QUARTER RESULTS
 MINNEAPOLIS, Dec. 19 /PRNewswire/ -- SCIMED Life Systems, Inc.


(NASDAQ: SMLS) today announced results for the third quarter ended Nov. 30, 1991.
 Sales for the quarter were $49,053,000 compared to $28,693,000 in the prior year. The company reported a loss for the quarter of $1,756,000, or $.12 per share, due to a pretax charge of $28 million in connection with settlement of patent litigation with Advanced Cardiovascular Systems, Inc. (ACS), a subsidiary of Eli Lilly and Company (Lilly). Sales for the nine months ended Nov. 30, 1991, were $135,574,000 compared to $78,992,000 in the prior year. Net earnings were $21,991,000, or $1.44 per share fully diluted, compared to $20,710,000, or $1.38 per share, in the prior year.
 Excluding the $28,000,000 pretax charge, third quarter operating profits increased 122 percent to $24,046,000 compared to $10,825,000 in the prior year.
 The company said that greater than expected sales were due to continued strong worldwide demand for its coronary angioplasty catheter and guiding catheter products. The company also believes third quarter sales benefited from inventory buildup by certain customers who feared supply interruptions caused by patent litigation with ACS and Lilly which was settled on Nov. 27, 1991.
 As previously announced, the company has entered into a broad agreement with ACS and Lilly which included a settlement of all existing patent litigation between the companies and also resolved potential future disputes over all existing and certain future products and patents. The company has one pending patent infringement suit with Schneider, Inc. regarding the EXPRESS(TM) catheter product.
 SCIMED Life Systems, Inc. develops, manufactures and markets disposable medical devices, principally coronary angioplasty catheters, for interventional treatment of coronary artery disease.
 SCIMED LIFE SYSTEMS, INC.
 STATEMENT OF OPERATIONS
 (Unaudited, in thousands, except per share data)
 Three Months Ended Nine Months Ended
 11/30/91 11/30/90 11/30/91 11/30/90
 Net sales $49,053 $28,693 $135,574 $78,992
 Cost of sales 7,960 7,797 26,242 20,849
 Gross profit 41,093 20,896 109,332 58,143
 Operating expenses:
 Selling, general
 and administrative 14,071 8,545 41,848 23,723
 Research and development 2,976 1,526 7,828 3,846
 Litigation settlement 28,000 -- 28,000 --
 Operating profit (loss) (3,954) 10,825 31,656 30,574
 Interest income 1,116 942 3,025 2,630
 Interest expense 1 37 4 167
 Other income (expense), net (21) 6 36 16
 Earnings (loss) before
 income taxes (2,860) 11,736 34,713 33,053
 Income tax expense
 (benefit) (1,104) 4,412 12,722 12,343
 Net earnings (loss) $(1,756) $7,324 $21,991 $20,710
 Primary earnings (loss)
 per common share $(.12) $.50 $1.46 $1.44
 Fully diluted earnings (loss)
 per common share $(.12) $.49 $1.44 $1.38
 Weighted average number of
 common and common equivalent
 shares outstanding 14,792 14,631 15,072 14,336
 -0- 12/19/91
 /CONTACT: Craig R. Dvorak of SCIMED, 612-420-0700/
 (SMLS) CO: SciMed Life Systems, Inc. ST: Minnesota IN: MTC SU: ERN


AL -- MN014 -- 4063 12/19/91 16:06 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 19, 1991
Words:541
Previous Article:COGNITRONICS WILL SELL OPTICAL SCANNING AND IMAGE PROCESSING LINE TO ITS FOUNDER; COMPANY WILL CONCENTRATE ON VOICE PROCESSING
Next Article:UNIVERSITY OF MINNESOTA AND ENDOTRONICS, INC. TO COLLABORATE ON DEVELOPMENT OF BIO-ARTIFICIAL DEVICE TO REPLACE LIVER FUNCTION
Topics:


Related Articles
SCIMED ANNOUNCES FIRST QUARTER RESULTS
SCIMED ANNOUNCES SECOND QUARTER RESULTS
SCIMED ANNOUNCES SECOND QUARTER RESULTS
SCIMED ANNOUNCES THIRD QUARTER RESULTS; SHIPS FIRST EXPRESS(R) RAPID EXCHANGE CATHETERS FROM ITS EUROPEAN FACILITY
SCIMED ANNOUNCES RECORD FIRST QUARTER RESULTS
SCIMED ANNOUNCES SECOND QUARTER RESULTS
SCIMED REPORTS FISCAL 1994 THIRD QUARTER RESULTS
SCIMED ANNOUNCES FOURTH QUARTER AND FISCAL 1994 RESULTS
SCIMED REPORTS SECOND QUARTER RESULTS
SCIMED REPORTS THIRD QUARTER RESULTS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters